Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy

被引:32
作者
Wang, Ping [1 ]
Yin, Tao [1 ]
Ma, Hong-Ying [1 ]
Liu, Dan-Qi [1 ]
Sheng, Yang-Hao [1 ]
Wang, Can [1 ]
Zhou, Bo-Ting [1 ,2 ]
机构
[1] Cent S Univ, Dept Pharm, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Inst Clin Pharmacol, Changsha 410078, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Carbamazepine; Genetic polymorphism; Plasma concentration; CYP3A4; CYP3A5; ABCB1; STEADY-STATE; ANTIEPILEPTIC DRUGS; SERUM CARBAMAZEPINE; VALPROIC ACID; PHARMACOKINETICS; EPOXIDE; CARBAMAZEPINE-10,11-EPOXIDE; PHARMACORESISTANCE; ASSOCIATION; EXPRESSION;
D O I
10.1016/j.eplepsyres.2015.09.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To examine the effects of cytochrome P450 3A4 (CYP3A4), cytochrome P450 3A5 (CYP3A5) and ATP-binding cassette sub-family B member 1 (ABCB1) genetic polymorphisms on carbamazepine (CBZ) plasma concentrations in Chinese patients with epilepsy using CBZ as monotherapy and bitherapy with phenytoin (PHT), phenobarbital (PB), or valproic acid (VPA). Methods: Eighty-eight Chinese patients with epilepsy were recruited from Xiangya Hospital Central South University, of whom 66 patients were placed in the CBZ monotherapy group, 10 patients were placed in the CBZ bitherapy group combined with one enzyme-inducing anti-seizure medications (PHT or PB), and 12 patients were placed in the CBZ bitherapy group combined with VPA. Carbamazepine and carbamazepine-10,11-epoxide (CBZ-E) plasma concentration of these patients were measured. In addition, the genetic polymorphisms of rs4646440 and rs2242480 in the CYP3A4 gene, rs15524 and rs776746 in the CYP3A5 gene, and rs1045642, rs2032582, rs10234411 and rs1128503 in the ABCBI gene of the cohort were genotyped. Subsequently, the associations between CBZ plasma concentrations and target single-nucleotide polymorphisms (SNPs), as well as haplotypes, were analysed. Results: In the CBZ monotherapy group, dose-adjusted CBZ concentrations were not associated with the eight SNPs and haplotypes. In the CBZ+PHT/PB group, rs776746, rs15524 and rs15524-rs776746 GT, AC haplotype were significantly associated with dose-adjusted CBZ plasma concentration (P=0.006, 0.006, 0.003, 0.003, respectively) and CBZ plus CBZ-E concentrations (P = 0.006, 0.006, 0.006, 0.006, respectively); rs2032582, rs10234411 and rs2032582-rs10234411 AT, and CA haplotype were associated with the CBZ-E/CBZ ratio (P=0.007, 0.004, 0.004, 0.007, respectively). Conclusions: rs776746 and rs15524 in the CYP3A5 gene tend to affect CBZ metabolism, and rs2032582, rs10234411 in the ABCB1 gene may contribute to inter-individual variation in CBZ and in CBZ-E transport among patients with epilepsy using CBZ in combination with PHT or PB. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 31 条
  • [1] BOURGEOIS BFD, 1984, THER DRUG MONIT, V6, P259, DOI 10.1097/00007691-198409000-00001
  • [2] Established antiepileptic drugs
    Brodie, MJ
    Dichter, MA
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 1997, 6 (03): : 159 - 174
  • [3] Chen CH, 2011, PHARMACOGENOMICS, V12, P1397, DOI [10.2217/PGS.11.103, 10.2217/pgs.11.103]
  • [4] The relationship between synonymous codon usage and protein structure in Escherichia coli and Homo sapiens
    Gu, WJ
    Zhou, T
    Ma, JM
    Sun, XA
    Lu, ZH
    [J]. BIOSYSTEMS, 2004, 73 (02) : 89 - 97
  • [5] How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine-10,11-epoxide in serum samples?
    Hermida, J
    Tutor, JC
    [J]. THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 384 - 388
  • [6] Evidence of significant contribution from CYP3A5 to hepatic drug metabolism
    Huang, WL
    Lin, YS
    McConn, DJ
    Calamia, JC
    Totah, RA
    Isoherranen, N
    Glodowski, M
    Thummel, KE
    [J]. DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) : 1434 - 1445
  • [7] Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data
    Jiao, Z
    Shi, XJ
    Zhao, ZG
    Zhong, MK
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (03) : 247 - 256
  • [8] HUMAN LIVER CARBAMAZEPINE METABOLISM - ROLE OF CYP3A4 AND CYP2C8 IN 10,11-EPOXIDE FORMATION
    KERR, BM
    THUMMEL, KE
    WURDEN, CJ
    KLEIN, SM
    KROETZ, DL
    GONZALEZ, FJ
    LEVY, RH
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (11) : 1969 - 1979
  • [9] Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
    Kuehl, P
    Zhang, J
    Lin, Y
    Lamba, J
    Assem, M
    Schuetz, J
    Watkins, PB
    Daly, A
    Wrighton, SA
    Hall, SD
    Maurel, P
    Relling, M
    Brimer, C
    Yasuda, K
    Venkataramanan, R
    Strom, S
    Thummel, K
    Boguski, MS
    Schuetz, E
    [J]. NATURE GENETICS, 2001, 27 (04) : 383 - 391
  • [10] Lynch T, 2007, AM FAM PHYSICIAN, V76, P391